Lista de obras -

Alcohol use and risk factors for self-harm behavior in Spanish adolescents

scientific article published on 29 March 2019

Are older adults also at higher psychological risk from COVID-19?

scientific article published on 01 September 2020

Breadth and depth of working memory and executive function compromises in mild cognitive impairment and their relationships to frontal lobe morphometry and functional competence

artículo científico publicado en 2019

COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls?

artículo científico publicado en 2020

Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?

artículo científico publicado en 2018

Cannabis use and cognitive impairment in schizophrenia and first-episode psychosis

scientific article published on 01 April 2019

Clinical staging in severe mental disorders; bipolar disorder, depression and schizophrenia

artículo científico publicado en 2018

Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences

artículo científico publicado en 2020

Could structural changes in the retinal layers be a new biomarker of mental disorders? A systematic review and thematic synthesis

scientific article published on 25 January 2019

Development and Validation of an Instrument for the Detection of Early Traumatic Experiences (ExpTra-S) in Patients With Psychosis

artículo científico publicado en 2020

Differential blood-based biomarkers of psychopathological dimensions of schizophrenia

artículo científico publicado en 2016

Difficulties in delivery and depressive symptomatology in schizophrenia

scientific article published on 12 February 2020

Early psychological impact of the 2019 coronavirus disease (COVID-19) pandemic and lockdown in a large Spanish sample

artículo científico publicado en 2020

Eating and nutritional habits in patients with schizophrenia

artículo científico publicado en 2019

Effectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design.

artículo científico publicado en 2013

Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia

artículo científico publicado en 2018

Factors associated with tobacco consumption in patients with depression

artículo científico publicado en 2019

History of Lifetime Cannabis Use Is Associated with Better Cognition and Worse Real-World Functioning in Schizophrenia Spectrum Disorders

scientific article published on 21 March 2019

Influence of secondary sources in the Brief Negative Symptom Scale

artículo científico publicado en 2018

It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline.

artículo científico publicado en 2016

Obstetric Phenotypes in the Heterogeneity of Schizophrenia

artículo científico publicado en 2018

Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia

artículo científico publicado en 2018

Predicting real-world functioning in outpatients with schizophrenia: Role of inflammation and psychopathology

scientific article published on 16 August 2019

Predictive factors of alcohol consumption in adolescents: data from 1-year follow-up prospective study

artículo científico publicado en 2019

Prevention of recurrent suicidal behavior: Case management and psychoeducation

artículo científico publicado en 2019

Psychometric evaluation of the negative syndrome of schizophrenia

artículo científico

Psychometric properties of a Spanish-version of the Schizophrenia Objective Functioning Instrument (Sp-SOFI)

article

S240. DETERMINANT FACTORS OF REAL-WORLD FUNCTIONING IN SCHIZOPHRENIA.

artículo científico publicado en 2018

Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia.

artículo científico publicado en 2018

Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study

scientific article published on 01 November 2019

Substance use or abuse, internet use, psychopathology and suicidal ideation in adolescents

artículo científico publicado en 2017

T17. OXIDATIVE STRESS BIOMARKERS AND NEGATIVE DIMENSION IN THE FIRST TEN YEARS OF SCHIZOPHRENIA: A 1-YEAR FOLLOW-UP STUDY.

artículo científico publicado en 2018

The negative syndrome of schizophrenia: three -underlying components are better than two.

artículo científico publicado en 2015

The Multi-Component Smoking Cessation Support Programme (McSCSP) is effective in patients with severe mental disorder without gender differences

artículo científico publicado en 2020

Tobacco and cognitive performance in schizophrenia patients: the design of the COGNICO study

artículo científico publicado en 2016

Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia

artículo científico publicado en 2020

Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia

artículo científico publicado en 2020

Validation of a Spanish version of the Columbia-Suicide Severity Rating Scale (C-SSRS).

artículo científico publicado en 2016

Will changes in alcohol and tobacco use be seen during the COVID-19 lockdown?

artículo científico publicado en 2020

Lista de obras de

Alcohol use and risk factors for self-harm behavior in Spanish adolescents

Are older adults also at higher psychological risk from COVID-19?

Breadth and depth of working memory and executive function compromises in mild cognitive impairment and their relationships to frontal lobe morphometry and functional competence

COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls?

Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?

Cannabis use and cognitive impairment in schizophrenia and first-episode psychosis

Clinical staging in severe mental disorders; bipolar disorder, depression and schizophrenia

Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences

Could structural changes in the retinal layers be a new biomarker of mental disorders? A systematic review and thematic synthesis

Development and Validation of an Instrument for the Detection of Early Traumatic Experiences (ExpTra-S) in Patients With Psychosis

Differential blood-based biomarkers of psychopathological dimensions of schizophrenia

Difficulties in delivery and depressive symptomatology in schizophrenia

Early psychological impact of the 2019 coronavirus disease (COVID-19) pandemic and lockdown in a large Spanish sample

Eating and nutritional habits in patients with schizophrenia

Effectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design.

Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia

Factors associated with tobacco consumption in patients with depression

History of Lifetime Cannabis Use Is Associated with Better Cognition and Worse Real-World Functioning in Schizophrenia Spectrum Disorders

Influence of secondary sources in the Brief Negative Symptom Scale

It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline.

Obstetric Phenotypes in the Heterogeneity of Schizophrenia

Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia

Predicting real-world functioning in outpatients with schizophrenia: Role of inflammation and psychopathology

Predictive factors of alcohol consumption in adolescents: data from 1-year follow-up prospective study

Prevention of recurrent suicidal behavior: Case management and psychoeducation

Psychometric evaluation of the negative syndrome of schizophrenia

Psychometric properties of a Spanish-version of the Schizophrenia Objective Functioning Instrument (Sp-SOFI)

S240. DETERMINANT FACTORS OF REAL-WORLD FUNCTIONING IN SCHIZOPHRENIA.

Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia.

Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study

Substance use or abuse, internet use, psychopathology and suicidal ideation in adolescents

T17. OXIDATIVE STRESS BIOMARKERS AND NEGATIVE DIMENSION IN THE FIRST TEN YEARS OF SCHIZOPHRENIA: A 1-YEAR FOLLOW-UP STUDY.

The negative syndrome of schizophrenia: three -underlying components are better than two.

The Multi-Component Smoking Cessation Support Programme (McSCSP) is effective in patients with severe mental disorder without gender differences

Tobacco and cognitive performance in schizophrenia patients: the design of the COGNICO study

Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia

Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia

Validation of a Spanish version of the Columbia-Suicide Severity Rating Scale (C-SSRS).

Will changes in alcohol and tobacco use be seen during the COVID-19 lockdown?